{"id":"W2795652858","doi":"10.1200/jco.2018.36.4_suppl.409","title":"A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma (PDAC) (MOBILITY-002 Trial, NCT02428270).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; London Health Sciences Centre; McMaster University; Cancer Care Ontario; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Trametinib; KRAS; FOLFIRINOX; MEK inhibitor; Progressive disease; Internal medicine; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Oncology; Phases of clinical research; Clinical trial; Chemotherapy; Kinase; MAPK/ERK pathway; Gastroenterology; Cancer; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001317216,0.001607152,0.00152201,0.0004199162,0.0003314783,0.0009475144,0.0007673856,0.00136221,0.01014376],"category_scores_gemma":[0.0007548436,0.0005473854,0.001069977,0.0003668267,0.0007131657,0.00108468,0.0005202646,0.002642731,0.001702071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008143429,"about_ca_system_score_gemma":0.001129768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006915863,"about_ca_topic_score_gemma":0.002166346,"domain_scores_codex":[0.999602,0.0002110995,0.00001509317,0.00006875518,0.00002528662,0.00007769206],"domain_scores_gemma":[0.9995822,0.00006550819,0.00009651753,0.0000305368,0.00001656466,0.0002086165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8665388,0.01955469,0.003476223,0.001441067,0.0009851789,0.0001859206,0.0001855134,0.002437299,0.01301932,0.0006013714,0.0102905,0.08128402],"study_design_scores_gemma":[0.8913679,0.09910982,0.004170772,0.00004743111,0.0001841131,0.0002064109,0.00003113492,0.0009234556,0.0008189622,0.000209326,0.002914146,0.00001653437],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742773,0.004708833,0.0007297614,0.001424887,0.0004443728,0.005565303,0.003877397,0.0002510568,0.008721225],"genre_scores_gemma":[0.9705969,0.002549537,0.002002021,0.001851712,0.0004010456,0.005853141,0.006326195,0.00005358636,0.01036577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01014376,"threshold_uncertainty_score":0.03393424,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1079135090782101,"score_gpt":0.486086792727875,"score_spread":0.378173283649665,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}